brain cancer /newsroom/taxonomy/term/8771/all en Arezu Jahani-Asl /newsroom/arezu-jahani-asl Wed, 23 Dec 2020 21:18:19 +0000 shirley.cardenas@mcgill.ca 254380 at /newsroom Air pollution nanoparticles linked to brain cancer /newsroom/channels/news/air-pollution-nanoparticles-linked-brain-cancer-302590 <p>New research from ºÚÁϲ»´òìÈ University links air pollution nanoparticles to brain cancer.</p> Wed, 13 Nov 2019 18:11:08 +0000 shirley.cardenas@mcgill.ca 188192 at /newsroom Major funding awarded to RI-MUHC scientists for innovative genomics geared to Quebec patients /newsroom/channels/news/major-funding-awarded-ri-muhc-scientists-innovative-genomics-geared-quebec-patients-286838 <p>Pioneering work to advance genomics and precision health treatments at the Research Institute of the ºÚÁϲ»´òìÈ University Health Centre (RI-MUHC) has been rewarded by Génome Québec. Dr. Nada Jabado and Dr. Ruth Sapir-Hichhadze, the RI-MUHC scientists who received the reward, were among the winners of a nation-wide competition emphasizing precision treatments in genomics.</p> Wed, 25 Apr 2018 16:39:29 +0000 justin.dupuis@mcgill.ca 38304 at /newsroom Encouraging results for patients with aggressive brain cancer /newsroom/channels/news/encouraging-results-patients-aggressive-brain-cancer-267254 <p>Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types of tumor respond well to treatment, others such as glioblastomas – the most common and aggressive brain tumors – are known to recur and progress within short times from the diagnosis. Patients diagnosed with this type of cancer, and who undergo current standard treatment, have a median survival of 16 months.</p> Thu, 23 Mar 2017 17:33:26 +0000 priya.pajel@mail.mcgill.ca 26806 at /newsroom